Radiation Kills Cancer Cells, But May Also Protect Some Tumor Stem Cells That Can Spread – MedicalResearch.com

MedicalResearch.com Interview with:

Jennifer Sims-Mourtada, Ph.D.Senior Rsearch ScientistDirector of Translational Breast Cancer ResearchCenter for Translational Cancer ResearchChristianaCare

MedicalResearch.com: What is the background for this study?

Response: Cancer stem cells are resistant cancer cells that are able to continuously grow and are very resistant to radiation and chemotherapy. Cancer stem cells can also escape to the blood stream and travel to another site causing metastasis.

MedicalResearch.com: What are the main findings?

Response: In this study we show that cancer stem cells depend on radiation induced inflammatory responses to survive radiation. Additionally we show that activation of IL-6-STAT3 pathway after radiation can make even non-cancer stem cells look like and behave as cancer stem cells. Thus any cell that survives radiation in the presence of certain inflammatory signals may be converted to a cancer stem cell.

MedicalResearch.com: What should readers take away from your report?

Response: Although radiation kills tumor cells, it can also activate inflammatory responses that may protect some tumor cells. Co-treatment with anti-inflammatory agents such as inhibitors to the IL-6 STAT 3 pathway may sensitize cancer stem cells to radiation induced death, and may prevent generation of new cancer stem cancer stem cells and improve outcomes in triple negative breast cancer.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Agents inhibiting the IL-6-STAT3 pathway are currently in clinical trials for breast cancer. Future work should focus on understanding radiation-induced inflammation in the context of both the immune response and tumor cells, as radiation induced inflammation can activate anti-tumor immunity as well as killing tumor cells. Some studies suggest that inhibition of IL-6 STAT3 signaling may also improve anti-tumor immunity, and thus these agents may target cancer cells by multiple mechanisms. It will be important to understand how these agents work to select which patients will respond to inhibition of this pathway and which ones will not.

MedicalResearch.com: Is there anything else you would like to add?

Response: This is the good and the bad of radiation. We know radiation induced inflammation can help the immune system to kill tumor cells thats good but also it can protect cancer stem cells in some cases, and thats bad. Whats exciting about these findings is were learning more and more that the environment the tumor is in its microenvironment is very important. Historically, research has focused on the genetic defects in the tumor cells. Were now also looking at the larger microenvironment and its contribution to cancer.

There are no disclosures to report

Citation:

Kimberly M. Arnold et al, Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells,International Journal of Radiation Biology(2019).DOI: 10.1080/09553002.2020.1705423

We respect your privacy and will never share your details.

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

See the article here:
Radiation Kills Cancer Cells, But May Also Protect Some Tumor Stem Cells That Can Spread - MedicalResearch.com

Humans soon able to regrow spines as body given ‘new power to heal itself’ – Daily Star

Scientists believe that humans will soon be able to recover from injuries such as broken spines, as treatment looks to boost the body's ability to heal itself.

A new study in the journal Regenerative Medicine describes how scientists were able to stimulate the self-repair response in rats.

Rats in the study were given two drugs, one of which is usually given to bone marrow transplant patients, and another which is used for bladder control.

This cocktail caused the rats' bone marrow to produce a greater number of mesenchymal stem cells, the cells which can develop into bone tissue.

As a result, enhanced calcium binding was seen at the site of the rats' spinal injuries, speeding up the production of new bone as well as healing wounds.

The study's authors hope that one day, such treatments will work on humans.

"We know that when bones break they will heal, and this requires the activation of stem cells in the bone," study co-author Sara Rankin from the National Heart and Lung Institute at Imperial College London, said in a statement.

"However, when the damage is severe, there are limits to what the body can do of its own accord.

"We hope that by using these existing medications to mobilise stem cells, as we were able to do in rats in our new study, we could potentially call up extra numbers of these stem cells, in order to boost our bodies' own ability to mend itself and accelerate the repair process."

Both drugs tested on rats are already widely used, so researchers are hopeful human trails can begin soon.

If these trials produce the same results as those seen in rats, then it's hoped the treatment could help to not only repair spinal injuries but also speed up the rate at which broken bones heal and mend damaged tissues in other organs.

Dr Tariq Fellous, first author of the research, said: "We first need to see if these medications release the stem cells in healthy volunteers before we can test them in patients with fractures.

"We have the drugs and know they are safe to use in humans we just need the funding for the human trials."

Dr Andia Redpath, who also co-authored the paper, added that repurposing existing medicines - so-called Regenerative Pharmacology - could have major potential as an efficient and cheaper way of treating diseases.

"Rather than devising new stem cell treatments from scratch that involve lengthy and expensive trials, our approach harnesses the power of the body's own stem cells, using existing drugs.

"We already know the treatments in our study are safe, it's now just a matter of exploring further if they help our bodies heal."

Stem cells are providing incredible new medical breakthroughs all the time.

Earlier this month, scientists trialled 3D-printed skin containing stem cells to treat burns victims .

Here is the original post:
Humans soon able to regrow spines as body given 'new power to heal itself' - Daily Star

Musculoskeletal Disorder Stem Cell Therapy Market Report 2019: With Essential Analysis of Market, Industry News and Policies by Regions, Top…

Musculoskeletal Disorder Stem Cell Therapy Market Scope of the Report:

The worldwide market for Musculoskeletal Disorder Stem Cell Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2018, according to a new study.

This report focuses on the Musculoskeletal Disorder Stem Cell Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2040936&source=atm

Musculoskeletal Disorder Stem Cell Therapy Market Segment by Manufacturers, this report covers

The key players covered in this studyOsiris TherapeuticsNuVasiveTakeda (TiGenix)Medi-post

Market segment by Type, the product can be split intoAllogeneicAutologous

Market segment by Application, split intoMuscle diseaseSkeletal disease

Market segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2040936&source=atm

Reasons to Purchase this Musculoskeletal Disorder Stem Cell Therapy Market Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis

* Market dynamics scenario, along with growth opportunities of the market in the years to come

* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment

* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

* 1-year analyst support, along with the data support in excel format.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2040936&licType=S&source=atm

The Musculoskeletal Disorder Stem Cell Therapy Market report has 150 tables and figures browse the report description and TOC:

Table of Contents

1 Study Coverage

1.1 Musculoskeletal Disorder Stem Cell Therapy Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Type

1.5 Market by Application

1.5.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Application

2 Executive Summary

2.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size

2.1.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue 2014-2025

2.1.2 Global Musculoskeletal Disorder Stem Cell Therapy Production 2014-2025

2.2 Musculoskeletal Disorder Stem Cell Therapy Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Musculoskeletal Disorder Stem Cell Therapy Manufacturers

2.3.2.1 Musculoskeletal Disorder Stem Cell Therapy Manufacturing Base Distribution, Headquarters

2.3.2.2 Manufacturers Musculoskeletal Disorder Stem Cell Therapy Product Offered

2.3.2.3 Date of Manufacturers Enter into Musculoskeletal Disorder Stem Cell Therapy Market

2.4 Key Trends for Musculoskeletal Disorder Stem Cell Therapy Markets & Products

3 Market Size by Manufacturers

3.1 Musculoskeletal Disorder Stem Cell Therapy Production by Manufacturers

3.1.1 Musculoskeletal Disorder Stem Cell Therapy Production by Manufacturers

3.1.2 Musculoskeletal Disorder Stem Cell Therapy Production Market Share by Manufacturers

3.2 Musculoskeletal Disorder Stem Cell Therapy Revenue by Manufacturers

3.2.1 Musculoskeletal Disorder Stem Cell Therapy Revenue by Manufacturers (2019-2025)

3.2.2 Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Manufacturers (2019-2025)

3.3 Musculoskeletal Disorder Stem Cell Therapy Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information.

Read the original post:
Musculoskeletal Disorder Stem Cell Therapy Market Report 2019: With Essential Analysis of Market, Industry News and Policies by Regions, Top...

Be a Bone Marrow Hero – University of Utah Health Care

Feb 25, 2020 12:00 AM

Every ten minutes, someone passes away from a blood disorder. Thats 148 people a day. There is a way to prevent many of these deathsa bone marrow transplant. DNA matching has the power to help thousands of people waiting for a life-saving bone marrow donation, but this special donor list depends entirely upon the willingness of individuals to sign up. Could your unique DNA hold the match that helps one person live to see tomorrow? Heres how you can find out.

Be The Match is a global hub for bone marrow donor registry working with hundreds of partners to support the transplant community. Signing up is easy online. You provide registration information, receive a kit in the mail, use the DNA swab as directed, and send it back for DNA typing. Your potentially life-saving information is secure and becomes available to specialized doctors around the world.

Even if you arent a match right away, the fact that every three minutes a person is diagnosed with a blood disorder means you could be called at any time to be a hero in someones time of need. Paloma Cariello, MD, MPH, says, Its absolutely a life-saving procedure. Its a new life that people getwe call it a new birthday, and at many hospitals they give it as a new birthday date in their chart. We sing Happy Birthday. Its a big event.

To find a close enough match to help fortify a patients immune system, doctors have to be precise. They first reach out to family, but even then, only 30% of patients find a good match. The odds of finding a match in an unrelated donor can be as low as 18%, especially with minorities.

The need for more individuals of every background cannot be overstated, says University of Utah Health Hematologist Sagar Patel, MD. He emphasizes the need for ethnic minorities to register. Every ethnicity is represented in the pool of patients, so the donor pool likewise needs to be diversified to improve the availability of similar DNA typing.

If a doctor finds you to be a suitable match, they select the ideal method for their patient and prepare you for donation. There are two donation methods: peripheral blood stem cell (PBSC) donation and bone marrow donation. Because every donor is carefully screened and prepared, and because a small amount of fluid is ultimately needed, neither procedure method impacts the performance of your own immune system, says Cariello.

With PBSC retrieval, you receive a stimulant for five days to increase the presence of blood-forming cells in your blood stream. Then a refined process of extraction occurs: Your blood is drawn, a machine collects just the cells the patient needs, and your remaining fluids are safely returned to you. This process can usually be done in one eight-hour session. Most donors report a full recovery within a week to 10 days, but you will be followed-up with until your full recovery.

If the doctor determines that the patient needs bone marrow, your procedure is a bit different. Marrow needs to be drawn from your pelvic bones. It happens in a hospital and under anesthesia, and you will feel no pain as the donation is collected. You can go back to routine activity the same day, and your system fully replenishes within four to six weeks.

Even with thousands of people in need, only about one in 430 donors in the Be The Match system are called in as a match. And the simple processes and expert professional care you receive minimize potential risk. A common side effect is bruising at the procedure sites, and some donors occasionally experience mild pain, fatigue, or dizziness. Reactions related to the use of anesthesia might also occur.

With such little risk, it shouldnt be a question as to whether you sign up, but when. And today is a perfect day. The low odds of finding a cure that these patients face are as extreme as the high rewards that await themand youwhen you make the choice to become a donor. Visit BeTheMatch.org to learn more and to become the one who initiates the miraculous call: We found a match.

See the original post:
Be a Bone Marrow Hero - University of Utah Health Care

R3 Stem Cell Heroes Program Performs Complimentary Regenerative Therapies on 70 Veterans in 2019 – PR Web

R3 Stem Cell Heroes Program - Free Regenerative Procedures for Veterans

LAS VEGAS (PRWEB) February 20, 2020

R3 Stem Cell, the nation's leader in regenerative therapies and provider training, announced that its Heroes Program was able to complete 70 complimentary stem cell procedures on military veterans in 2019. The veterans traveled from all over the US to receive the regenerative therapies at no cost.

At the R3Stem Cell Training Course for doctors, providers of all kinds learn how to perform regenerative procedures in a supervised setting. This includes stem cell and exosome procedures on military veterans of all ages and from all branches of service. Any veteran can be nominated (or nominate themselves), and the pain being experienced does not have to be a result of a service related injury.

According to R3 Stem Cell CEO David Greene, MD, MBA, "When we hear the stories of these Veterans and what they have done for America, it's so exciting to be able to do something to help improve their quality of life. Especially Veterans of the Vietnam War, all they wanted to do was protect our country. To see how well they do afterwards and then refer in their Veteran friends for procedures, it's amazing!"

The chosen Veterans receive an evaluation by the Board Certified doctors who are trainers, and then procedures include whatever amount of regenerative biologic deemed appropriate. The Veteran patients are followed up the R3 staff, and invited back for additional therapies when necessary.

To date over 70 Veterans have successfully receive regenerative therapies in the program. Over a dozen patients are treated at each workshop, with more opportunities upcoming. Added Dr. Greene, "Our stem cell courses are extremely hands on an providers love it. They have been increasing in popularity continuously, which allows us to treat more Veterans!"

For those who would like to nominate a Veteran for the Heroes Program to receive free stem cell therapy, simply visit https://r3stemcell.com/hero or call (844) GET-STEM.

Share article on social media or email:

Originally posted here:
R3 Stem Cell Heroes Program Performs Complimentary Regenerative Therapies on 70 Veterans in 2019 - PR Web

PROGRESS 2020: Business briefs – The Times

FINANCIAL SERVICES

West-AirComm Federal Credit Union

West-AirComm Federal Credit Union has been a proud part of Beaver County for more than 70 years. Founded in 1949 by the employees of Westinghouse Electric, the credit union has its roots deep within the industry of the region.

West-AirComm serves more than 20,000 members with both technology and personal service. The financial services include investments and loans at some of the best rates in the region, free checking, first mortgages and home equity loans.

West-AirComm puts the credit union mission of People Helping People into motion on a daily basis. The staff offers personal service if you have questions about your finances.

The staff also volunteers their personal time to charitable organizations in the community. In 2019, they volunteered more than 1,200 hours and raised $11,000 for the spotlight charity, Operation Troop Appreciation.

West-AirComms 2020 charity initiative Cruisin for a Cause, will benefit the Beaver County Association for the Blind. The nonprofit organizations mission is to provide services to blind and visually impaired persons that promote their independence, prevent blindness and give those who are blind or disabled employment opportunities. The money raised help to fund the associations goal to provide a better means of transportation to the visually impaired.

From being deeply rooted in industry to providing financial services and supporting the communities it serves, West-AirComm cares about its members.

For more information, visit http://www.westaircomm.com or visit any one of the branches in Beaver, Aliquippa or Moon Township.

Farmers Building and Savings Bank

ROCHESTER Farmers Building and Savings Bank, 290 West Park in Rochester, specializes in mortgage loans, home equity loans and home improvement loans. The bank also offers do-it-yourself construction loans to enable those who have construction knowledge to assist in the building of their home.

The bank has drive-through facilities and off-street parking. It is handicapped accessible.

Farmers provides premium-rate passbook savings that earn interest from day of deposit to the day of withdrawal.

What is unique about our passbook savings accounts is that they are not internet accessible. This helps alleviate identity theft issues, said Dennis L. Goehring, president and managing officer. You, the account holder, bring in your passbook for transactions. Its simple and safe.

Farmers also offers Christmas club accounts and direct deposit of payroll, Social Security and pension checks. Funds are insured by the Federal Deposit Insurance Corp.

Farmers Building and Savings Bank is one of Beaver Countys few remaining independent financial associations. All employees and managers are from the Beaver County area and boast more than 150 years of combined banking experience. They include Martin Samchuck, Rita L. Hinton, Sarah Brogley, Pamela Locke and Dennis L. Goehring. Since the bank was founded in 1894, theyve employed only 17 individuals.

More information is available by calling the bank at 724-774-4970. Youll speak with a real person, not an automated answering system.

Friendly Federal Credit Union

ALIQUIPPA Friendly Federal Credit Union, 2000 Main St. in Aliquippa, is a full-service institution that continues to expand its offerings and membership.

Friendly Federal offers auto loans, home equity loans, holiday and vacation clubs, mortgages, IRAs, certificates of deposit, money markets, free checking, direct deposit, a youth club, debit and credit cards, home banking, bill pay and an onsite ATM machine.

For the past 18 years, the institution has received the Bauer Financial five-star rating for exceptional performance. This year, it celebrates 65 years of service.

The credit union was founded in 1955 as the J&L Service Department Employees Federal Credit Union. The J&L Byproducts, Seamless and Steelworkers Credit Union joined the institution. In 1986, the financial facilitys name was changed to Friendly Federal Credit Union. Today, the credit union has assets of more than $53 million, with a membership of about 5,000.

Cynthia Hladio is the chief executive officer/manager. Phyllis Heckman is the branch manager. Carl E. Hennen is the chairman; Ed Murphy is the treasurer; and Lynn Nero, Helen Pane, Sue Ronosky, Amy Walker and Deanna Ross are directors.

The branch office is located at 384 State St. in Baden.

Information: 724-375-0488; 724-869-3500; http://www.friendlyfcu.org.

AUTOMOTIVE SERVICE

Myers Service Center & Quality Quick Lube

BEAVER In January 1990, Rick Myers and his sons, Rick and Ron, opened an auto repair business at 475 Buffalo St. in Beaver. They wanted Myers Service Center & Quality Quick Lube to do three things: be honest and upfront with customers, provide quality, affordable work each and every time, and earn the continued loyalty and trust of each customer.

Thirty years later, the Myers family has been blessed to have so many returning customers, many of whom they consider extended family, and blessed to have dedicated auto technicians and employees.

To Mark, Matt, John, Paige, Gray, Alaina and Paul, thank you for your dedication and for giving customers excellent service day-in and day-out. That commitment to excellence is what makes the business successful.

The Myers family business couldnt have succeeded without these great employees and loyal customers. Thank you. Myers Service Center and Quick Lube looks forward to continuing such service for many years to come.

Information: 724-774-7655.

EDUCATION

Geneva College

BEAVER FALLS Geneva College prepares undergraduate students to serve faithfully and fruitfully in their lifes work. With a vocational focus and liberal arts core, a Geneva education is grounded in Gods word, enabling students to think, write and communicate well in todays world.

For traditional students, Geneva offers more than 145 majors and programs, including biology business, communication, computer science, education, engineering, nursing, psychology and student ministry. The faculty cares about the success of each student, and the 13-to-1 student-faculty ratio makes that possible. Geneva professors have real-world work experience, academic achievements, and are actively engaging the culture through research and writing while professing an active Christian faith.

In addition, Geneva fields 18 varsity sports teams in NCAA Division III athletics for men and women, hosts intramural sports leagues and coordinates more than 200 student activities each year.

Adult undergraduates can earn a degree at Geneva in as few as 16 months and complement their professional and family commitments with full online programs.

The masters degree programs MBA, counseling, cybersecurity, higher education and leadership studies can help students excel toward a more promising future. These high-demand professional degrees equip students for principled Christian service to their organizations and the world.

In 2019, U.S. News & World Report ranked Geneva as the No. 3 Best Value Regional University for combining high academic quality with affordability. Kiplingers Personal Finance also lists Geneva on its prestigious list of national Private Universities of Value.

Genevas main campus is located in Beaver Falls. The college is governed by the Reformed Presbyterian Church of North America.

Geneva College does not discriminate on the basis of race, color, sex, disability, and national or ethnic origin.

Information: 800-847-8255; http://www.geneva.edu.

Penn State-Beaver

CENTER TWP. Penn State Beaver offers the personal experience of a small campus with the resources of a Big Ten research university. Students come from western Pennsylvania as well as 28 states and seven foreign countries to live in our newly remodeled residence hall, participate in our championship-winning intercollegiate sports and learn from award-winning faculty.

Students and the community now have an opportunity to participate in the Beaver Valley LaunchBox, a signature program of Invent Penn State, a commonwealth-wide initiative to promote entrepreneurship and innovation in the region and help spur economic development, job creation and campus-community collaboration.

The LaunchBox is powered by community business leaders, professors and ambitious students to provide subject matter expertise and training to help local entrepreneurs and innovators to build and grow their businesses and convert their ideas into a reality successfully. We have partnered with the Beaver County Library System to establish Creative Corners in each of the countys public libraries. We also offer community workshops in the libraries and on the Penn State Beaver campus.

To learn more about the Beaver Valley LaunchBox and our community programs visit on Facebook, Twitter, Instagram and at beavervalley.launchbox.psu.edu.

Pennsylvania Cyber Charter School

MIDLAND Educating children in kindergarten through 12th grade, the Pennsylvania Cyber Charter School, better known as PA Cyber, is one of the largest and most experienced online public schools in the nation.

Students will find creative online learning environments, personalized instruction and top-notch curriculum at PA Cyber. Qualified, state-certified teachers use rich academic content that is aligned to state standards and meets the approval of the Pennsylvania Department of Education.

PA Cybers instructional model focuses on its students. It recognizes their changing developmental stages while respecting their differences and unique abilities. Using a flexible but focused learning model, PA Cybers teachers create a personalized education program for each student.

Headquartered in Midland, PA Cyber has offices throughout Pennsylvania. They serve as a hub for enrollment, orientation and enrichment. The nearly 10,000 students enrolled in PA Cyber belong to a real community, where they grow academically, emotionally, socially and physically.

PA Cyber offers choices for live and self-paced instruction, along with a variety of opportunities for interaction with teachers and peers. The extensive course list and program offerings include the creative and performing arts, STEM and gifted programs, advanced placement classes, and a variety of clubs and other activities. Certified faculty and staff are available to engage with students and families at their convenience.

PA Cyber provides a tuition-free, accredited curriculum with access to all technology and the personal guidance students need for success. The technology platforms are leading edge, user-friendly and enhance the educational experiences of the students. Each student receives a laptop, printer, textbooks and online connectivity, as well as an expert technological support team that is responsive, skilled and dependable.

PA Cyber graduates can be found attending highly regarded universities, colleges, professional academies and vocational schools. Any school-aged child living in Pennsylvania may enroll.

Information: 888-722-9237; http://www.pacyber.org.

Community College of Beaver County

CENTER TWP. Community College of Beaver County, the second smallest community college in Pennsylvania, accomplished big things in 2019 on its Center Township campus.

In March, Roger W. Davis was named the colleges ninth president after serving as interim president since May 2018. Davis, who holds a doctorate in urban educational leadership from Morgan State University in Baltimore, is the colleges youngest president. He joined CCBC in July 2016 as executive vice president and provost.

Academically, CCBC launched the School of Industrial Technology and Continuing Education. The School of Aviation Science founded by James M. Johnson was renamed in his honor. The program, which celebrated 50 years of flight, offers the No. 1 aviation training program in the nation. It includes four two-year degree programs professional pilot, air traffic control, aerospace management and unmanned aerial vehicle (drones).

Additionally, Nursingprocess.org ranked CCBCs nursing school fifth in the nation, and G.I. Jobs magazine named the community college a military-friendly school. CCBC also received the Carnegie Science Award for Leadership in STEM education of its high school academies, and is the first non-profit higher education program in the state to provide digital textbooks for a single low-cost fee.

For more than 50 years, CCBC has been a gateway to success for area students and continues to provide a path to prosperity and family-sustaining careers.

Clarion University of Pennsylvania

Clarion Universitys more than 4,700 determined students are building a bright future through challenging academics and diverse interests, all while living in a charming, civic-minded town that embraces them.

Clarion offers undergraduate and graduate degree programs in business, education, health science and the arts with a 19-to-1 student-to-faculty ratio, and nationally and internationally accredited programs. The university leads Pennsylvanias State System of Higher Education with 28 national accreditations and offers a multitude of internship and study abroad opportunities that give students hands-on experience in their chosen field and in research before they earn their degree.

The university is comprised of its scenic campus in Clarion, which has evolved since its seminary beginnings in 1867, its Clarion University-Venango campus in Oil City and Clarion Online, which offers excellence in education from anywhere in the world.

The 2020 US News and World Report ranks Clarion Online in its Top 100: best online bachelors programs and business programs, best online nursing graduate programs and best online master of education programs.

With a focus on professional development, the university has launched inventive programming and certificates. The Respiratory Care three-year bachelors program prepares students to be registered respiratory therapists and work in diverse roles through the health care delivery system.

The Department of Special Education and Disability Policy Studies and the Competent Learner Model Center of Excellence announced new, online certificate programs. Undergraduate and graduate level certificates in assistant applied behavior analyst and competent learner model are available as well as an advanced competency certificate program for special education students.

The university also offers an online opioid treatment certificate, the first of its kind in the Pennsylvania State System of Higher Education.

More than 160 student organizations complement 175-plus academic programs, including academic, Greek, political, multi-cultural and service groups. Students from 42 states and 15 countries attend Clarion which boasts 58,236 alumni worldwide.

ENTERTAINMENT

Sheffield Lanes, Lounge

ALIQUIPPA Once again this summer, Sheffield Lanes and Lounge in Aliquippa will expand.

Owners Rick and Jeannie DAgostino and their son, Zach, plan to enlarge Rickey Dees Pizza kitchen. Since it reopened in 2009, the former Crescent Township-based business has become an integral part of Sheffield Lanes.

During these winter months, live entertainment continues. With the vinyl sides down, the veranda, warmed by a gas fireplace and heaters, is the perfect place to enjoy local musicians, wonderful food and a beverage. The veranda, which opened last May and provides customers with a non-smoking area, is a great place for private parties.

Sheffield Lanes offers a comfortable smoking lounge and wide selection of bourbon and Scotch, as well as many domestic and craft beers. The lounge also features a humidor stocked with premium cigars. Local musicians play several evenings during the week.

The state-of-the-art Pro Shop, managed by Matt Mowad, recently completed its third second year of business and is quickly becoming a premier spot for bowlers to upgrade their equipment or buy their first bowling ball. The Pro Shop opens at 1 p.m. on Monday, Tuesday and Friday, and at 11 a.m. on Wednesday and Saturday.

The lower-level Fallout Shelter, which will celebrate its 12th anniversary in March, is an intimate venue for live music, special events and private parties. The Shelter is a host to the Beaver County Cigar Club which meets the Thurd Thursday of each month. The cigar club plans to hold its fourth Knob Creek Single Barrel Bourbon release party this summer.

Sheffield Lanes has been a local landmark since it opened in 1950 as a 12-lane duckpin center. Now, the landmark is a 20-lane, 10-pin center that hosts mens, womens, mixed and youth bowling leagues. During the week, Sheffield Lanes offers open bowling specials including Family Funday on Sunday and Electric Bowl on Friday and Saturday. The facility also hosts birthday parties, corporate events, and family and class reunions.

Sheffield Lanes is a go-to spot for league and recreational bowlers who enjoy music, good food, and a well-stocked bar. The friendly staff knows many of their patrons on a first-name basis and strives to keep things running smoothly.

Sheffield Lanes is looking forward to summer with the veranda, open-air deck and bocce courts. Stop by.

Information: 724-375-5080; http://www.sheffieldlanes.com.

FOOD

Oram's Donut Shop

BEAVER FALLS For more than 80 years, Orams Donut Shop, 1406 Seventh Ave. in Beaver Falls, has delighted customers with its famous cinnamon rolls and donuts. Orams takes pride in making fried pastries the old-fashioned way from scratch with quality ingredients and original family recipes.

Customers in Beaver County show appreciation to Orams year after year by voting it the Best Doughnut Shop in The Times Best of the Valley contest. Orams appreciates the community support and will continue to produce the best sweet treats for Beaver County.

Each week, the creative staff at Orams comes up with exciting new flavors. Past specials have included the original cinnamon roll with maple-cream cheese icing and a pumpkin cream cheese-filled doughnut rolled in cinnamon-powdered sugar. To learn about the weekly specials at Orams, follow the shops Facebook, Twitter, Google and Instagram accounts.

Customers can now order their favorite doughnuts online by visiting the shops website, http://www.Orams.com. Online orders require a minimum of a dozen doughnuts and orders must be submitted before 8 p.m. for next day pickup. Orams continues to take orders by phone.

Hours: 5 a.m. to 2 p.m. Monday through Saturday.

To order: 724-846-1504; http://www.orams.com, http://www.facebook.com/oramsdonuts

Rosalind Candy Castle

NEW BRIGHTON Rosalind Candy Castle, 1301 Fifth Ave. in New Brighton, is a full-line chocolate candy manufacturer, wholesaler and retailer. Specialties include custom favors for weddings, showers and anniversaries, fund-raising candy and gifts for all occasions.

Rosalind Candy Castle has been in business for 106 years and employs 30 people. The century-old business offers an extensive line of chocolate confections made from scratch.

Jim Crudden is the president of Rosalind Candy Castle. His children Michael, vice president of operations and Jennifer, vice president of sales and marketing are carrying on the family tradition of manufacturing chocolates using the original recipes. Crudden believes the business is successful because of the passion and dedication of its employees, who treat each other like family.

The business continues to expand through new retail outlets and popular fundraising programs, used by many schools and organizations throughout western Pennsylvania. The redesigned company website also has led to growth throughout the United States.

See the original post here:
PROGRESS 2020: Business briefs - The Times

Mum meets the stem cell donor who saved her four-year-old son’s life – Nottinghamshire Live

A mum has shared the emotional experience of meeting the stranger who saved her son's life.

Alfie Commons, now aged four, was just seven months old when he was diagnosed with leukaemia in 2016.

After three rounds of chemotherapy failed, Alfie received a life-saving bone marrow donation from a school teacher in Germany, who recently made the trip to the UK to meet him.

Alfie's mum, Lorna Commons, 40, of Toton has spoken about the experience in the hope it will encourage more people to sign up to become potential donors.

Looking back to the day of diagnosis, she said Alfie had been to his GP for a third time in February 2016 after suffering a cold since Christmas.

She said: "The GP told us to go to A&E for further tests as he was a little concerned.

"We got to Queen's Medical Centre in the morning and by early evening, we had the diagnosis; Alfie had infant acute lymphoblastic leukaemia (ALL)."

Ms Commons, who works in HR, added: "Even now, four years down the line, I still feel the emotions of that day. Nothing can prepare you."

The plan was to treat Alfie with chemotherapy, but after the first round failed, Ms Commons was told his only chance of survival was to get a bone marrow transplant.

The family was told Alfie was unlikely to leave hospital for the next six months.

She added: "Worse was to follow, his second course also failed and on the same day, we were told that Alfies nine-year-old brother, Billy, wasnt a bloodstemcellmatch for him either.

"The fear of losing Alfie was overwhelming, I felt helpless but I had to carry on for Alfies sake.

The transplant could not go ahead without the cancer being near enough eradicated and even when the good news came that a donor had been located, Alfie still had a mountain to climb.

After a third failed round of chemotherapy, Alfie was put on a trial immunotherapy drug as a '"last ditch attempt". Against all the odds, it worked.

"I think at that point all the doctors and nurses were preparing us for the worst. Your head has to go there," Ms Commons said.

"But then the cancer went, and it was enough to give us the bridge to getting the transplant done."

While the transplant was a success, Alfie suffered for months with Graft versus Host Disease (GvHD) on his skin and in his gut, which is the body's reaction to the new stem cells.

However, doctor's were encouraged the body was gradually accepting the cells and beginning to produce cells of their own.

On February 19, Alfie and his mum were able to meet the woman who saved his life after she made the 600-mile trip.

Christin Bouvier, 34, from Schwerin in Germany, was matched with Alfie after she registered in 2010 with DKMS, a charity dedicated to the fight against blood cancer.

The school teacher had been on the bloodstemcellregister for a number of years before she was contacted and tested as a match for Alfie.

Ms Bouvier said: When they told me that the recipient was a baby I just cried.

"Its a moment that is always with me and whenever I feel a bit down, I think back to it as it always brings me so much happiness!"

Ms Commons said she had been able to contact Ms Bouvier anonymously, as per UK law, but they were permitted to meet two years after the transplant.

Ms Bouvier added: It was always a dream to meet Lorna and Alfie and I never thought it would happen I was so delighted when Lorna invited me. I was very nervous but also very excited to meet them both in person.

"I knew the meeting would be one of those very special moments in my life."

Ms Commons feels the meeting has meant a new chapter has begun in both hers and Alfie's life and she is now focussed on the positives.

She added: "For something so small, there really is no greater gift than being a donor - I get to see my child grow up. To meet Christin, I was able to say 'this is what you've done'.

"We will be in each other's lives forever now - Alfie has her DNA in his blood. But Christin and I also share a special bond, we're just so similar and some people say we even look like sisters.

Alfie is such a special little boy and I truly believe that this story can make a real difference and save more lives.

"There is a match out there for everyone with blood cancer, people just need to come forward and register."

Anyone aged between 17-55 and in general good health can go on standby as a potential lifesaver.

View original post here:
Mum meets the stem cell donor who saved her four-year-old son's life - Nottinghamshire Live

Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets – Yahoo Finance

Global Genetic Testing Services Market by Test Type (Prenatal Testing, Newborn Screening, Predictive and Presymptomatic Testing), Application, Service Provider, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Newark, NJ, Feb. 25, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, theglobal genetic testing services market is expected to grow from USD 34.5 Billion in 2017 to USD 67.1 Billion by 2025 at a CAGR of 8.72% during the forecast period 2018-2025. Rising prevalence of genetic diseases, awareness among population, growing adoption of genetic testing services, and demand of genetic testing in developed countries, growing demand for personalized medicine, growing government initiatives and increased R&D activities in the genetic testing market are the factors that is driving genetic testing services market.

Genetic testing is used in the analysis of the changes in chromosomes, proteins, or genes caused by any suspected genetic condition or disease. It is also used in the diagnosis of cancer and plan the treatment. Several genetic tests are used such as new-born screening, prenatal testing, pre-implantation testing, carrier testing, etc. Numerous methods such as chromosomal method, molecular method and biochemical method are used for genetic testing. It is performed for the identification of risk factors, to screen the new-borns, and also in forensics. According to the report by WHO, sickle cell anaemia is one of the most common genetic disorders among people whose ancestors come from Sub-Saharan Africa, South America, Cuba, Central America, Saudi Arabia, India, and Mediterranean countries. Genetic tests in combination with other genomic technologies predict risk of an individual to a disease and also increase the opportunities for players in pharmaceutical industry to grow. For instance, and provides genetic makeup tests to the consumers. Company also recommends genetic counsellors based on results to help the consumers about the better testing of genes, and the inherited diseases.

Advancements in genetic testing technologies, rising cases of genetic diseases and growing awareness are driving the testing market. In addition, emerging markets hold great potential for growth of due to growing awareness and increase in patients in these regions. High cost and lack of experienced professionals are some of the factors restraining the growth of the market. However, Shift from clinical science to bioinformatics is also leading to high rate of adoption of genetic testing technology, which in turn is augmenting the growth of the market in coming years.

DOWNLOAD FREE SAMPLE REPORT AThttps://www.fiormarkets.com/report-detail/362223/request-sample

Key players operating in the global genetic testing services market include Laboratory Corporation of America Holdings, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Quest Diagnostics, Eurofins Scientific, Ambry Genetics, Hoffmann-La Roche Ltd, Illumina, Inc., CENTOGENE AG, 23andMe, Sequenom, GeneDx, Abbott, Cepheid Inc., ELITech Group, Verinata Health, Inc and others. Top players of the market are making efforts in R&D to increase their footprint in the market.

The predictive & presymptomatic testing is dominating the segment and was valued around USD 12.17 billion in 2017

The test type segment includes prenatal testing, newborn screening, predictive and presymptomatic testing, pharmacogenomic testing. The predictive & presymptomatic testing is dominating the segment and was valued around USD 12.17 billion in 2017. Detection of diseases at early stage minimizes the severity of diseases leading to reduced mortality rate. Increasing prevalence of chronic diseases around the world is expected to augment the segment growth over the forecast period.

The oncology segment dominated the application segment and is expected to register the highest CAGR of 10.07% in the forecast period

The application segment is divided into segments such as oncology, infectious diseases and autoimmune diseases. The oncology segment dominated the application segment and is expected to register the highest CAGR of 10.07% in the forecast period. Timely diagnosis save lives and reduce the number of deaths. According to, The Institute for Health Metrics and Evaluation (IHME), around 8.9 million cancer deaths were recorded in 2016 caused by inheriting genetic mutation. Rising prevalence of various types of cancer such as prostate cancer, breast cancer and lung cancer coupled with increasing awareness pertaining to early detection of cancer are expected to stimulate the growth of the market.

Story continues

The hospital-based laboratories segment is dominating the genetic testing services market and held the largest market share of 38.21% in 2017

The service provider segment is classified into hospital-based laboratories, diagnostic laboratories and specialty clinics. The hospital-based laboratories segment is dominating the genetic testing services market and held the largest market share of 38.21% in 2017. Advanced infrastructure and increasing number of hospitals in developing economies are driving the growth of the market.

Browse full report with TOC athttps://www.fiormarkets.com/report/global-genetic-testing-services-market-by-test-type-362223.html

Regional Segment Analysis of the Genetic Testing Services Market

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global genetic testing services market with the largest share and was valued around USD 15.180 Billion in 2017 where as Asia Pacific region is the fastest growing region in the market. North America region is dominating the market due to developed infrastructure, increase in health care investments and presence of large number of academic and research institutes are key factors leading to the growth of the market. Asia Pacific is anticipated to register highest growth in the forecast period. Increase in the prevalence of infectious disease, increasing awareness about the advantages of predictive testing, and rise in the adoption of advanced technology for clinical applications are some of the major factors offering growth opportunities to the genetic testing services market.

About the report:

The global genetic testing services market is analysed on the basis of value (USD Billion). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porters five forces model, attractiveness analysis, raw material analysis, supply, demand analysis, competitor position grid analysis, distribution and marketing channels analysis.

For Instant Purchase:

Customization of the Report:

The report can be customized as per client requirements. For further queries, you can contact us onsales@fiormarkets.comor +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

About Fior Markets

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.

Contact Us

Avinash DHead of Business DevelopmentPhone:+1-201-465-4211Email:sales@fiormarkets.comWeb:www.fiormarkets.com

To know more market research reports and industry analysis, visit our associate website: https://www.magnifierresearch.com

Related Reports

Global Cell Therapy Technologies Market - https://www.fiormarkets.com/report/global-cell-therapy-technologies-market-by-product-consumables-376050.htmlGlobal Dental 3D Printing Market - https://www.fiormarkets.com/report/global-dental-3d-printing-market-by-product-and-376051.htmlGlobal Gene Therapy Market - https://www.fiormarkets.com/report/global-gene-therapy-market-by-type-germline-gene-376052.htmlGlobal Health Intelligent Virtual Assistant Market - https://www.fiormarkets.com/report/global-health-intelligent-virtual-assistant-market-by-products-376053.html

Read the original post:
Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets - Yahoo Finance

New study identifies trigger that turns dormant cancer stem cells into active ones – PR Web

DURHAM, N.C. (PRWEB) February 26, 2020

A new study released today in STEM CELLS identifies, for the first time, two morphologically and functionally different types of cancer stem cells found in cervical cancer. Of the two types, one exhibits an overexpression of cPLA2, a key enzyme that triggers the transformation of dormant cancer stem cells into active ones, resulting in cervical cancer metastasis and recurrence. The information in this study could lead to new targets for treatments to halt tumor recurrence and metastatic spread. Also, it might accelerate the development of combination therapies.

The current standard of treatments for cervical cancer the second leading cause of cancer death in young women worldwide is radiotherapy and chemotherapy. However, the cancers resistance to chemotherapy and radiation, combined with a tendency to metastasis in the lymph nodes or recur in the pelvis, leaves doctors searching for more effective treatments.

Cervical cancer stem cells (CCSCs) are considered the major culprit behind the cancers ability to overcome these treatments. At the same time, a majority of cancer stem-like cells or tumor-initiating cells remain dormant. It takes a change in their microenvironment to spur them to metastasize.

The mechanisms responsible for this must be identified to design more suitable therapies for the different subpopulations of cancer stem cells (CSCs) in various tissue-specific cancers, said Hua Guo, Ph.D., who headed up the investigation along with Yuchao He, Ph.D. The two are colleagues at Tianjin Medical University Cancer Institute and Hospital. Researchers at Tianjin University of Traditional Chinese Medicine and at the Center for Translational Cancer Research, Peking University First Hospital, also participated in the study.

Although several cell surface antigens have been identified in CCSCs, these markers vary among tumors because of CSC heterogeneity. However, whether these markers specifically distinguish CCSCs with different functions is unclear. The study published in STEM CELLS sought to resolve this question. And in fact, its findings demonstrate that CCSCs exist in two biologically distinct phenotypes, characterized by different levels of cPLA2 expression.

Our study showed for the first time that overexpression of cPLA2 results in a phenotype associated with mesenchymal traits, including increased invasive and migration abilities. On the other hand, CCSCs with cPLA2 downregulation show dormant epithelial characteristics, said Dr. Guo. In addition, cPLA2 regulates the reversible transition between mesenchymal and epithelial CCSC states through PKC, an atypical protein that governs cancer cell state changes.

Dr. He added, Now that we know cPLA2 triggers this transformation, we believe that cPLA2 might be an attractive therapeutic target for eradicating different states of CCSCs to eliminate tumors more effectively.

The novel study by Dr. Guo and team is of very high importance in understanding the transition between dormant cancer stem cells, which evade chemotherapy and radiation treatments, and actively dividing cells which can be better targeted, said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS. I applaud the group for this important discovery which will help researchers develop better treatments for cervical cancer.

###

The full article, cPLA2 reversibly regulate different subsets of cancer stem cells transformation in cervical cancer, can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3157.

Figure Caption: This study revealed that there are two morphologically and functionally distinct cancer stem cell populations regulated by cPLA2 in cervical cancer. cPLA2 might be a unique marker to identify different cancer stem cell populations and trigger quiescent epithelial cancer stem cells transform to invasive mesenchymal states. Overexpression of cPLA2 resulted in a CD44+CD24- phenotype with mesenchymal traits, whereas cervical cancer stem cells (CCSCs) with cPLA2 downregulation expressed CD133 and showed epithelial characteristics. cPLA2, as a key role to reversely regulate CCSCs states and EMT, might provide innovative therapeutic strategies intended to halt tumor recurrence and metastasis.

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS (http://www.StemCells.com) is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Share article on social media or email:

View original post here:
New study identifies trigger that turns dormant cancer stem cells into active ones - PR Web

Induced Pluripotent Stem Cells (iPSCs) Market in 2020: Global Industry Size, Demand, Growth & Development, Trends, Insights and Forecast until…

Induced Pluripotent Stem Cells (iPSCs) Market Research Report is provided on past, current and anticipated market situations, market drivers, trends driving it, and the challenges faced by the market which will help in deciding corporate strategy, product strategy, marketing strategy and sales strategy. The report also contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Induced Pluripotent Stem Cells (iPSCs) Market Report is analyzed for major factors such as consumer needs and changes observed in them over time, market sales in terms of value and volume, emerging opportunities, market growth trends, factors driving this market, threats associated with them and market performance of key vendors along with key regions.

Get Free Exclusive Sample of this Premium Report at @ https://www.esherpamarketreports.com/request-sample/es-379889/

Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Type, covers

Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Applications, can be divided into

Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Manufacturers, this report covers:

Hanssem,Aria Furniture,EMONS,Muse Furniture,Man Wah Holdings,La-Z-Boy,Natuzzi Editions,Ashley Furniture,Ekornes

Table of Contents1 Induced Pluripotent Stem Cells (iPSCs) Market Overview1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)1.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate Comparison by Type 2020 VS 20261.2.2 Compact Type Induced Pluripotent Stem Cells (iPSCs)1.2.3 Standard Type Induced Pluripotent Stem Cells (iPSCs)1.3 Induced Pluripotent Stem Cells (iPSCs) Segment by Application1.3.1 Induced Pluripotent Stem Cells (iPSCs) Consumption Comparison by Application: 2020 VS 20261.4 Global Induced Pluripotent Stem Cells (iPSCs) Market by Region1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Estimates and Forecasts by Region: 2020 VS 20261.4.2 North America Estimates and Forecasts (2015-2026)1.4.3 Europe Estimates and Forecasts (2015-2026)1.4.4 China Estimates and Forecasts (2015-2026)1.4.5 Japan Estimates and Forecasts (2015-2026)1.5 Global Induced Pluripotent Stem Cells (iPSCs) Growth Prospects1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Estimates and Forecasts (2015-2026)1.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Production Capacity Estimates and Forecasts (2015-2026)1.5.3 Global Induced Pluripotent Stem Cells (iPSCs) Production Estimates and Forecasts (2015-2026)2 Market Competition by Manufacturers2.1 Global Induced Pluripotent Stem Cells (iPSCs) Production Capacity Market Share by Manufacturers (2015-2020)2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers (2015-2020)2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.4 Global Induced Pluripotent Stem Cells (iPSCs) Average Price by Manufacturers (2015-2020)2.5 Manufacturers Induced Pluripotent Stem Cells (iPSCs) Production Sites, Area Served, Product Types2.6 Induced Pluripotent Stem Cells (iPSCs) Market Competitive Situation and Trends2.6.1 Induced Pluripotent Stem Cells (iPSCs) Market Concentration Rate2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue2.6.3 Mergers & Acquisitions, Expansion3 Production Capacity by Region3.1 Global Production Capacity of Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2015-2020)3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2015-2020)3.3 Global Induced Pluripotent Stem Cells (iPSCs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.4 North America Induced Pluripotent Stem Cells (iPSCs) Production3.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2015-2020)3.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.5 Europe Induced Pluripotent Stem Cells (iPSCs) Production3.5.1 Europe Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2015-2020)3.5.2 Europe Induced Pluripotent Stem Cells (iPSCs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.6 China Induced Pluripotent Stem Cells (iPSCs) Production3.6.1 China Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2015-2020)3.6.2 China Induced Pluripotent Stem Cells (iPSCs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)3.7 Japan Induced Pluripotent Stem Cells (iPSCs) Production3.7.1 Japan Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2015-2020)3.7.2 Japan Induced Pluripotent Stem Cells (iPSCs) Production Capacity, Revenue, Price and Gross Margin (2015-2020)4 Global Induced Pluripotent Stem Cells (iPSCs) Consumption by Regions4.1 Global Induced Pluripotent Stem Cells (iPSCs) Consumption by Regions4.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Consumption by Region4.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Market Share by Region5 Production, Revenue, Price Trend by Type5.1 Global Induced Pluripotent Stem Cells (iPSCs) Production Market Share by Type (2015-2020)5.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2015-2020)5.3 Global Induced Pluripotent Stem Cells (iPSCs) Price by Type (2015-2020)5.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End6 Global Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Application6.1 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Market Share by Application (2015-2020)6.2 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Growth Rate by Application (2015-2020)7 Company Profiles and Key Figures in Induced Pluripotent Stem Cells (iPSCs) Business7.2.4 Main Business and Markets Served8 Induced Pluripotent Stem Cells (iPSCs) Manufacturing Cost Analysis8.1 Induced Pluripotent Stem Cells (iPSCs) Key Raw Materials Analysis8.1.1 Key Raw Materials8.1.2 Key Raw Materials Price Trend8.1.3 Key Suppliers of Raw Materials8.2 Proportion of Manufacturing Cost Structure8.3 Manufacturing Process Analysis of Induced Pluripotent Stem Cells (iPSCs)8.4 Induced Pluripotent Stem Cells (iPSCs) Industrial Chain Analysis9 Marketing Channel, Distributors and Customers9.1 Marketing Channel9.2 Induced Pluripotent Stem Cells (iPSCs) Distributors List9.3 Induced Pluripotent Stem Cells (iPSCs) Customers10 Market Dynamics10.1 Market Trends10.2 Opportunities and Drivers10.3 Challenges10.4 Porters Five Forces Analysis11 Production and Supply Forecast11.1 Global Forecasted Production of Induced Pluripotent Stem Cells (iPSCs) (2021-2026)11.2 Global Forecasted Revenue of Induced Pluripotent Stem Cells (iPSCs) (2021-2026)11.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSCs) (2021-2026)11.4 Global Induced Pluripotent Stem Cells (iPSCs) Production Forecast by Regions (2021-2026)11.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Production, Revenue Forecast (2021-2026)11.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Production, Revenue Forecast (2021-2026)11.4.3 China Induced Pluripotent Stem Cells (iPSCs) Production, Revenue Forecast (2021-2026)11.4.4 Japan Induced Pluripotent Stem Cells (iPSCs) Production, Revenue Forecast (2021-2026)12 Consumption and Demand Fprecast12.1 Global Forecasted and Consumption Demand Analysis of Induced Pluripotent Stem Cells (iPSCs)12.2 North America Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Country12.3 Europe Market Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Country12.4 Asia Pacific Market Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Regions12.5 Latin America Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs)13 Forecast by Type and by Application (2021-2026)13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)13.1.1 Global Forecasted Production of Induced Pluripotent Stem Cells (iPSCs) by Type (2021-2026)13.1.2 Global Forecasted Revenue of Induced Pluripotent Stem Cells (iPSCs) by Type (2021-2026)13.1.2 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSCs) by Type (2021-2026)13.2 Global Forecasted Consumption of Induced Pluripotent Stem Cells (iPSCs) by Application (2021-2026)14 Reseach Finding and Conclusion15 Methodology and Data Source15.1 Methodology/Research Approach15.1.1 Research Programs/Design15.1.2 Market Size Estimation15.1.3 Market Breakdown and Data Triangulation15.2 Data Source15.2.1 Secondary Sources15.2.2 Primary Sources15.3 Author List15.4 Disclaimer. And More

Click Here For Detailed Table Of Contents

Enquire before purchasing this report @ https://www.esherpamarketreports.com/pre-order-enquiry/es-379889

Reasons To Buy:

Purchase this Report with Full Access @ https://www.esherpamarketreports.com/purchase/es-379889/

Contact Us:

Name: Jason George

Email: [emailprotected]

Call :USA: +1 408 757 0510

Organization: eSherpa Market Reports

About Us:

eSherpa Market Reports is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Here is the original post:
Induced Pluripotent Stem Cells (iPSCs) Market in 2020: Global Industry Size, Demand, Growth & Development, Trends, Insights and Forecast until...